Dysregulation of IFN-γ signaling pathways in the absence of TGF-β1

Journal of Immunology

Volumn 169, Issue 10, 2002, Pages 5941-5947

  McCartney Francis, Nancy L ^a   Wahl, Sharon M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; INTERFERON REGULATORY FACTOR 1; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; STAT1 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CACHEXIA; ENZYME ACTIVITY; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFLAMMATION; LONGEVITY; MOUSE; NONHUMAN; NULL CELL; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 0037111393     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.10.5941     Document Type: Article

References (46)

1. Zamora, R., Y. Vodovotz, and T. R. Billiar. 2000. Inducible nitric oxide synthase and inflammatory diseases. Mol. Med. 6:347.
2. Abramson, S, B., A. R. Amin, R. M. Clancy, and M. Attur. 2001. The role of nitric oxide in tissue destruction. Best Pract. Res. Clin. Rheumatol. 15:831.
3. McCartney-Francis, N., J. B. Allen, D. E. Mizel, J. E. Albina, Q. W. Xie, C. F. Nathan, and S. M. Wahl. 1993. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178:749.
4. G-monomethyl-L-arginine. J. Exp. Med. 179:651.
5. Stefanovic-Racic, M., K. Meyers, C. Meschter, J. W. Coffey, R. A. Hoffman, and C. H. Evans. 1994. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum. 37:1062.
6. McCartney-Francis, N. L., X. Y. Song, D. E. Mizel, C. L. Wahl, and S. M. Wahl. 1999. Hemoglobin protects from streptococcal cell wall-induced arthritis. Arthritis Rheum. 42:1119.
7. McCartney-Francis, N. L., X. Song, D. E. Mizel, and S. M. Wahl. 2001. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease. J. Immunol 166:2734.
8. Vodovotz, Y., C. Bogdan, J. Paik, Q. W. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178:605.
9. Vodovotz, Y., A. G. Geiser, L. Chesler, J. J. Letterio, A, Campbell, M. S. Lucia, M. B. Sporn, and A. B. Roberts. 1996. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor β1 null mouse. J. Exp. Med. 183:2337.
10. Kulkami, A. B., C. G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. 1993. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90:770.
11. McCartney-Francis, N. L., M. Frazier-Jessen, and S. M. Wahl. 1998. TGF-β: A balancing act. Int. Rev. Immunol. 16:553.
12. Geiser, A. G., J. J. Letterio, A. B. Kulkarni, S. Karlsson, A. B. Roberts, and M. B. Sporn. 1993. Transforming growth factor β1 (TGF-β1) controls expression of major histocompatibility genes in the postnatal mouse: Aberrant histocompatibility antigen expression in the pathogenesis of the TGF-β1 null mouse phenotype. Proc. Natl. Acad. Sci. USA 90:9944.
13. McCartney-Francis, N. L., D. E. Mizel, R. S. Redman, M. Frazier-Jessen, R. B. Panek, A. B. Kulkami, J. M. Ward, J. B. McCarthy, and S. M. Wahl. 1996. Autoimmune Sjögren's-like lesions in salivary glands of TGF-β1-deficient mice are inhibited by adhesion-blocking peptides. J. Immunol. 157:1306.
14. Dang, H., A. G. Geiser, J. J. Letterio, T. Nakabayashi, L. Kong, G. Fernandes, and N. Talal. 1995. SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-β knockout mice. J. Immunol 155:3205.
15. Hines, K. L., A. B. Kulkami, J. B. McCarthy, H. Tian, J. M. Ward. M. Christ, N. L. McCartney-Francis, L. T. Furcht, S. Karlsson, and S. M. Wahl. 1994. Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor β1 knockout mice. Proc. Natl. Acad. Sci. USA 91:5187.
16. Christ, M., N. L. McCartney-Francis, A. B. Kulkarni, J. M. Ward, D. E. Mizel, C. L. Mackall, R. E. Gress, K. L. Hines, H. Tian, S. Karlsson, et al. 1994. Immune dysregulation in TGF-β1-deficient mice. J. Immunol. 153:1936.
17. Nakabayashi, T., J. J. Letterio, A. G. Geiser, L. Kong, N. Ogawa, W. Zhao, T. Koike, G. Fernandes, H. Dang, and N. Talal. 1997. Up-regulation of cytokine mRNA adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-β1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-β1 knockout mice. J. Immunol. 158:5527.
18. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051.
19. Xie, Q. W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-κB/Ret in induction of nitric oxide synthase. J. Biol. Chem. 269:4705.
20. Martin, E., C. Nathan, and Q. W. Xie. 1994. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:977.
21. Samuel, C. E., and K. Ozato. 1996. Induction of interferon-induced genes. Biotherapy 8:183.
22. Gao, J., D. C. Morrison, T. J. Parmely, S. W. Russell, and W. J. Murphy. 1997. An interferon-γ-activated site (GAS) is necessary for full expression of the iNOS gene in response to interferon-γ and lipopolysaccharide. J. Biol. Chem. 272:1226.
23. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, S. I. Koh, T. Kimura, S. J, Green, et al. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612.
24. Carrasco, D., J. Cheng, A. Lewin, G. Warr, H. Yang, C. Rizzo, F. Rosas, C. Snapper, and R. Bravo. 1998. Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein. J. Exp. Med. 187:973.
25. Salkowski, C. A., S. A. Barber, G. R. Detore, and S. N. Vogel. 1996. Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes. J. Immunol. 156:3107.
26. Meraz, M. A., J. M. White, K. C. Sheehan. E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431.
27. Misko, T. P., R. J. Schilling, D. Salvemini, W. M. Moore, and M. G. Currie. 1993, A fluorometric assay for the measurement of nitrite in biological samples. Anal, Biochem. 214:11.
28. Connor, J. R., P. T. Manning, S, L, Settle, W. M. Moore, G. M. Jerome, R. K. Webber, F. S. Tjoeng, and M. G. Currie. 1995. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol. 273:15.
29. Wahl, S., N. McCartney-Francis, and J. Orenstein. 1999. Eat your heart out. Microbes Infect. 1:1244.
30. Roberts, A. B., Y. Vodovotz, N. S. Roche, M. B. Sporn, and C. F. Nathan. 1992. Role of nitric oxide in antagonistic effects of transforming growth factor-β and interleukin-1β on the beating rate of cultured cardiac myocytes. Mol. Endocrinol. 6:1921.
31. Brahmajothi, M. V., and D. L. Campbell. 1999. Heterogeneous basal expression of nitric oxide synthase and superoxide dismutase isoforms in mammalian heart: Implications for mechanisms governing indirect and direct nitric oxide-related effects. Circ. Res. 85:575.
32. McCartney-Francis, N. L., D. E. Mizel, M. Frazier-Jessen, A. B. Kulkami, J. B. McCarthy, and S. M. Wahl. 1997. Lacrimal gland inflammation is responsible for ocular pathology in TGF-β1 null mice. Am. J. Pathol. 151:1281.
33. Miller, M. J., J. H. Thompson, X. J. Zhang, H. Sadowska-Krowicka, J. L. Kakkis, U. K. Munshi, M. Sandoval, J. L. Rossi, S. Eloby-Childress, J. S. Beckman, et al. 1995. Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology 109:1475.
34. Wu, G. S., J. Zhang, and N. A. Rao. 1997. Peroxynitrite and oxidative damage in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 38:1333.
35. Kolb, H., and V. Kolb-Bachofen. 1998. Nitric oxide in autoimmune disease: Cytotoxic or regulatory mediator? Immunol. Today 19:556.
36. Grisham, M. B., D. Jourd'Heuil, and D. A. Wink. 1999. Nitric oxide. 1. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation. Am. J. Physiol. 276:G315.
37. Pine, R., A. Canova, and C. Schindler. 1994. Tyrosine phosphorylated p9l binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNα and IFN-γ, and is likely to autoregulate the p91 gene. EMBO J. 13:158.
38. Shiraishi, A., J. Dudler, and M. Lotz. 1997. The role of IFN regulatory factor-1 in synovitis and nitric oxide production. J. Immunol. 159:3549.
39. Tada, Y., A. Ho, T. Matsuyama, and T. W. Mak. 1997. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. J. Exp. Med. 185:231.
40. Gao, J. J., M. B. Filla, M. J. Fultz, S. N. Vogel, S. W. Russell, and W. J. Murphy. 1998. Autocrine/paracrine IFN-αβ mediates the lipopolysaccharide-induced activation of transcription factor Stat1-α in mouse macrophages: Pivotal role of Stat1α in induction of the inducible nitric oxide synthase gene. J. Immunol. 161:4803.
41. Nguyen, H., J. Hiscott, and P. M. Pitha. 1997. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev. 8:293.
42. Jacobs, A. T., and L. J. Ignarro. 2001. Lipopolysaccharide-induced expression of interferon-β mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. J. Biol. Chem. 276:47950.
43. Chen, W., W. Jin, H. Tian, P. Sicurello, M. Frank, J. M. Orenstein, and S. M. Wahl. 2001. Requirement for transforming growth factor β1 in controlling T cell apoptosis. J. Exp. Med. 194:439.
44. Bachmaier, K., N. Neu, C. Pummerer, G. S. Duncan, T. W. Mak, T. Matsuyama, and J. M, Penninger. 1997. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 96:585.
45. Kojda, G., and K. Kottenberg. 1999. Regulation of basal myocardial function by NO. Cardiovasc. Res. 41:514.
46. Brady, A. J., P. A. Poole-Wilson, S. E. Harding, and J. B. Warren. 1992. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am. J. Physiol. 263:H1963.